Can Psychedelics Alleviate Symptoms of Cluster Headache and Accompanying Mental Health Problems? A Case Report Involving Hawaiian Baby Woodrose
Johnson, S., & Black, Q. C. | Journal of Psychoactive Drugs | 7 May 2020
Psilocybin and LSD Have No Long-Lasting Effects in an Animal Model of Alcohol Relapse
Meinhardt, M. W., Güngör, C., Skorodumov, I., Mertens, L. J., & Spanagel, R. | Neuropsychopharmacology | 5 May 2020
Chronic pain and psychedelics: a review and proposed mechanism of action
Castellanos, J. P., Woolley, C., Bruno, K. A., Zeidan, F., Halberstadt, A., & Furnish, T. | Regional Anesthesia & Pain Medicine | 4 May 2020
The Viability of Microdosing Psychedelics as a Strategy to Enhance Cognition and Well-being – An Early Review
Bornemann, J. | Journal of Psychoactive Drugs | 2 May 2020
Psychedelics and Psychedelic-Assisted Psychotherapy
Reiff, C. M., Richman, E. E., Nemeroff, C. B., Carpenter, L. L., Widge, A. S., Rodriguez, C. I. | American Journal of Psychiatry | 1 May 2020
Ayahuasca – potential therapeutic properties in psychiatry. Research review
Barabasz-Gembczyk, A., & Kucia, K. | Psychiatr. Pol. | 30 April 2020
A Single Administration of the Atypical Psychedelic Ibogaine or Its Metabolite Noribogaine Induces an Antidepressant-Like Effect in Rats
Rodríguez, P., Urbanavicius, J., Prieto, J. P., Fabius, S., Reyes, A. L., Havel, V., ... & Carrera, I. | ACS Chemical Neuroscience | 24 April 2020
Dynamic coupling of whole-brain neuronal and neurotransmitter systems
Kringelbach, M. L., Cruzat, J., Cabral, J., Knudsen, G. M., Carhart-Harris, R., Whybrow, P. C., ... & Deco, G. | Proceedings of the National Academy of Sciences | 13 April 2020
Registered Clinical Trials Investigating Ketamine for Psychiatric Disorders
Peyrovian, B., McIntyre, R., Phan, L., Lui, L. M., Gill, H., Majeed, A., ... & Rosenblat, J. D. | Journal of Psychiatric Research | 9 April 2020
Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin
Dahmane, E., Hutson, P. R., & Gobburu, J. V. | Clinical Pharmacology in Drug Development | 06 April 2020
Psychedelic Psychiatry’s Brave New World
Nutt, D., Erritzoe, D., & Carhart-Harris, R. | Cell | 2 April 2020
Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review
Heuschkel, K., & Kuypers, K. P. | Frontiers in Psychiatry | 31 March 2020
Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications.
O’Callaghan, C., Hubik, D. J., Dwyer, J., Williams, M., & Ross, M. | Journal of Music Therapy | 30 March 2020
Long-term effects of psychedelic drugs: A systematic review
Aday, J. S., Mitzkovitz, C. M., Bloesch, E. K., Davoli, C. C., & Davis, A. K. | Neuroscience & Biobehavioral Reviews | 15 March 2020
Reviewing the Potential of Psychedelics for the Treatment of PTSD.
Krediet, E., Bostoen, T., Breeksema, J., van Schagen, A., Passie, T., & Vermetten, E. | International Journal of Neuropsychopharmacology | 14 March 2020
The Psychedelic Renaissance and Its Forensic Implications
Holoyda, B. | The journal of the American Academy of Psychiatry and the Law | 09 Mar 2020
Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users: Associations with Mystical, Challenging, and Enduring Effects.
Lancelotta, R. L., & Davis, A. K. | Journal of Psychoactive Drugs | 09 Mar 2020
Natural Psychoplastogens As Antidepressant Agents
Benko, J., & Vranková, S. | Molecules | 5 March 2020
Psilocybin Therapeutic Research: The Present and Future Paradigm
Kargbo, R. B. | ACS Medicinal Chemistry Letters | 2 March 2020
Psychedelics and Dying Care: A Historical Look at the Relationship Between Psychedelics and Palliative Care
Dyck, E. | Journal of psychoactive drugs | 1 March 2019
Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities.
Rosenbaum, D., Weissman, C., Anderson, T., Petranker, R., Dinh-Williams, L. A., Hui, K., & Hapke, E. | Journal of Psychopharmacology | 28 February 2020
Self-reported negative outcomes of psilocybin users: A quantitative textual analysis
Bienemann, B., Ruschel, N. S., Campos, M. L., Negreiros, M. A., & Mograbi, D. C. | Plos one | 21 February 2020
Subacute Effects of the Psychedelic Ayahuasca on the Salience and Default Mode Networks
Pasquini, L., Palhano-Fontes, F., & de Araujo, D. B. | medRxiv | 21 February 2020
Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance
Wolff, M., Evens, R., Mertens, L. J., Koslowski, M., Betzler, F., Gründer, G., & Jungaberle, H. | Frontiers in Psychiatry | 21 February 2020
Posttraumatic Growth After MDMA‐Assisted Psychotherapy for Posttraumatic Stress Disorder
Gorman, I., Belser, A. B., Jerome, L., Hennigan, C., Shechet, B., Hamilton, S., ... & Feduccia, A. A. | Journal of Traumatic Stress | 19 February 2020